What was once a concern about public goods has transformed into a social crusade with a political agenda.
Recent regulations are unlikely to make the MSP program a platform for more robust health insurance competition.
How can we cut health care costs while expanding access to care?
Is licensing more important for doctors than for interior decorators or hair braiders?
Despite recent e orts, the United States remains a long way from a Hatch‐Waxman breakthrough for biologic drugs.